NCT05462496 2024-10-15Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic CancerIcahn School of Medicine at Mount SinaiPhase 2 Recruiting25 enrolled
NCT03891979 2020-06-26Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic AdenocarcinomaNYU Langone HealthPhase 4 Withdrawn